| Lysosomotropic agents C De Duve, T De Barsy, B Poole, P Tulkens Biochemical pharmacology 23 (18), 2495-2531, 1974 | 2383 | 1974 |
| Aminoglycosides: activity and resistance MP Mingeot-Leclercq, Y Glupczynski, PM Tulkens Antimicrobial agents and chemotherapy 43 (4), 727-737, 1999 | 1425 | 1999 |
| Tackling antibiotic resistance K Bush, P Courvalin, G Dantas, J Davies, B Eisenstein, P Huovinen, ... Nature Reviews Microbiology 9 (12), 894-896, 2011 | 1288 | 2011 |
| Aminoglycosides: nephrotoxicity MP Mingeot-Leclercq, PM Tulkens Antimicrobial agents and chemotherapy 43 (5), 1003-1012, 1999 | 1107 | 1999 |
| Pseudomonas aeruginosa: resistance and therapeutic options at the turn of the new millennium N Mesaros, P Nordmann, P Plésiat, M Roussel-Delvallez, J Van Eldere, ... Clinical microbiology and infection 13 (6), 560-578, 2007 | 855 | 2007 |
| Antibiotic efflux pumps F Van Bambeke, E Balzi, PM Tulkens Biochemical pharmacology 60 (4), 457-470, 2000 | 644 | 2000 |
| Quinolones in 2005: an update F Van Bambeke, JM Michot, J Van Eldere, PM Tulkens Clinical Microbiology and infection 11 (4), 256-280, 2005 | 540 | 2005 |
| Effect of a collaborative approach on the quality of prescribing for geriatric inpatients: a randomized, controlled trial A Spinewine, C Swine, S Dhillon, P Lambert, JB Nachega, L Wilmotte, ... Journal of the American Geriatrics Society 55 (5), 658-665, 2007 | 409 | 2007 |
| Tissue concentrations: do we ever learn? JW Mouton, U Theuretzbacher, WA Craig, PM Tulkens, H Derendorf, ... Journal of Antimicrobial Chemotherapy 61 (2), 235-237, 2008 | 377 | 2008 |
| Intracellular distribution and activity of antibiotics PM Tulkens European journal of clinical microbiology and infectious diseases 10, 100-106, 1991 | 358 | 1991 |
| Pharmacodynamic Evaluation of the Intracellular Activities of Antibiotics against Staphylococcus aureus in a Model of THP-1 Macrophages M Barcia-Macay, C Seral, MP Mingeot-Leclercq, PM Tulkens, ... Antimicrobial agents and chemotherapy 50 (3), 841-851, 2006 | 331 | 2006 |
| MECHANISM OF AMINOGLYCOSIDE-INDUCED LYSOSOMAL PHOSPHOLIPIDOSIS: IN VITRO AND IN VZVO STUDIES WITH GENTAMICIN AND AMIKACIN P TULKENS Biochemical pharmacology 31 (23), 3861-3870, 1982 | 310 | 1982 |
| Hepatic safety of antibiotics used in primary care RJ Andrade, PM Tulkens Journal of Antimicrobial Chemotherapy 66 (7), 1431-1446, 2011 | 292 | 2011 |
| Glycopeptide antibiotics: from conventional molecules to new derivatives F Van Bambeke, Y Van Laethem, P Courvalin, PM Tulkens Drugs 64, 913-936, 2004 | 292 | 2004 |
| Antibiotic efflux pumps in prokaryotic cells: occurrence, impact on resistance and strategies for the future of antimicrobial therapy F Van Bambeke, Y Glupczynski, P Plesiat, JC Pechere, PM Tulkens Journal of Antimicrobial Chemotherapy 51 (5), 1055-1065, 2003 | 281 | 2003 |
| Early effects of gentamicin, tobramycin, and amikacin on the human kidney ME De Broe, GJ Paulus, GA Verpooten, F Roels, N Buyssens, R Wedeen, ... Kidney international 25 (4), 643-652, 1984 | 248 | 1984 |
| Renal cell apoptosis induced by nephrotoxic drugs: cellular and molecular mechanisms and potential approaches to modulation H Servais, A Ortiz, O Devuyst, S Denamur, PM Tulkens, ... Apoptosis 13, 11-32, 2008 | 244 | 2008 |
| Intracellular pharmacodynamics of antibiotics S Carryn, H Chanteux, C Seral, MP Mingeot-Leclercq, F Van Bambeke, ... Infectious Disease Clinics 17 (3), 615-634, 2003 | 242 | 2003 |
| Aminoglycoside-induced renal phospholipidosis and nephrotoxicity G Laurent, BK Kishore, PM Tulkens Biochemical pharmacology 40 (11), 2383-2392, 1990 | 236 | 1990 |
| Comparative stability studies of antipseudomonal β-lactams for potential administration through portable elastomeric pumps (home therapy for cystic fibrosis patients) and motor … E Viaene, H Chanteux, H Servais, MP Mingeot-Leclercq, PM Tulkens Antimicrobial agents and chemotherapy 46 (8), 2327-2332, 2002 | 228 | 2002 |
